Glyra – GLP-1 Tracker
Glyra – GLP-1 Tracker is made and published by CONTIBL LIMITED. AppBrain is an independent app data site and isn't affiliated with CONTIBL LIMITED. The app name, icon, screenshots and description belong to CONTIBL LIMITED and are shown as published on the App Store.
AppBrain's verdict
- Rating on App Store
- 5.00
- 1 ratings
- Last updated
- October 10, 2026
It doesn't have enough ratings yet to judge what users think.
Rankings
App Store top chartsApp Store Rankings for Glyra – GLP-1 Tracker
Competitors
Similar apps and more from CONTIBL LIMITEDAlternatives to Glyra – GLP-1 Tracker
Releases
Updates seen on the App Store- Version
- 1.1.7
- Launched
- June 2026
No changelog data
User feedback
Ratings and reviews on the App StoreComments on Glyra – GLP-1 Tracker for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 68.3 MB
- Content rating
- Medium
Technologies used by Glyra – GLP-1 Tracker
About the app and developer
About Glyra – GLP-1 Tracker
Glyra – GLP-1 Tracker is a health & fitness app developed by CONTIBL LIMITED.
User Ratings
Glyra – GLP-1 Tracker is rated 5.00 out of 5 stars. The rating is based on one rating ratings.
App Information
Glyra – GLP-1 Tracker is freely available from the App Store. The app size is 68.26 MB. The latest version available is 1.1.7. The last update was on October 10, 2026.
Technical Requirements
The app has a content rating of Medium Maturity. The app has been available on the App Store since June 2026.
Developer information for CONTIBL LIMITED
Address:
Store listing
By CONTIBL LIMITED, from the App StoreDescription by CONTIBL LIMITED Written by the developer, not by AppBrain. Click to read.
Log your medication, see how levels may change over time, understand side effects at a glance, and keep weight and daily habits in one calm place. Works with GLP-1 therapies and weight-management medication—including Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Victoza, Trulicity, Rybelsus, semaglutide, tirzepatide, liraglutide, dulaglutide, and Retatrutide.
WHY GLYRA
Weight loss Progress & BMI:
Track your weight loss overtime and view your BMI on a simple gauge, alongside dose status and what’s coming next on your schedule.
Estimated medication levels:
Glyra models how your level may rise and taper between logged doses — with separate curves for tirzepatide, semaglutide, and retatrutide based on your dose history. A visual way to connect timing, amount, and how you feel between doses.
Side-effect snapshot chart:
See side effects on a spider-style chart so patterns stand out quickly — useful for your own notes and for conversations with your care team.
Share Your Journey (camera graph filter):
Capture a photo with your weight-progress graph overlaid on the image — made for sharing milestones without rebuilding a chart in another app.
Visit-ready CSV & PDF export:
Export a formatted PDF summary (weight change, dose and side-effect overview) plus CSV for spreadsheets. Built for records you may want to bring to an appointment.
CORE TRACKING
• Dose log — medication, amount (mg), injection site, pain level, notes, scheduled vs completed
• Calendar & daily log — weight, calories, protein, water, and general notes by day
• Weight & progress charts — follow trends across flexible time ranges
• Dose reminders and optional daily check-in reminders
• Light and dark appearance
PRIVATE BY DESIGN
• No sign-in account — your tracking data stays on your device
• Delete all app data anytime in Settings
WHO IT’S FOR
Adults using GLP-1 medications who want dose scheduling, level estimates, side-effect visibility, calorie/nutrition logging and weight tracking in one focused app — without ads for unrelated products or a cluttered social feed.
SUBSCRIPTION INFORMATION*
A Glyra subscription is required to access the app and its features after any applicable free trial. If you subscribe, payment will be charged to your Apple Account at confirmation of purchase, unless a free trial applies, in which case payment is charged when the trial ends.
The subscription automatically renews unless auto-renew is turned off at least 24 hours before the end of the current period. You can manage your subscription and turn off auto-renew in Apple Account Settings. Your account will be charged for renewal within 24 hours before the end of the current period. If you subscribe before a free trial ends, any unused portion of the trial will be forfeited.
Health disclaimer:
Glyra is not a medical device. Glyra is for personal tracking and education only. It does not provide medical advice, diagnosis, or treatment. Medication Level estimates are illustrative models, not lab results. Always follow your prescriber’s plan and talk to a qualified healthcare professional about doses, side effects, and goals.
Not intended for children under 13.
Privacy: https://www.glyraapp.com/privacy
Terms: https://www.glyraapp.com/terms
Support/Feedback: support@glyraapp.com